ESMO

• Press releases
• Country: United States

Phrontline Biopharma Highlights Encouraging Preliminary Safety and Antitumor Activity of TJ101 Presented at ESMO 2026 and Announces Phase Ib Initiation

Preliminary responses observed in 6 of 8 evaluable urothelial carcinoma patients (75%), including patients previously treated with enfortumab vedotin and pembrolizumab Early antitumor activity also observed in squamous NSCLC, SCLC and prostate cancer SHANGHAI and HANGZHOU, China, Oct. 29,...

• Press releases
• Country: United States

Hengrui presenta investigaciones innovadoras en el Congreso ESMO 2026

-De China al escenario global: Hengrui presenta investigaciones innovadoras en el Congreso ESMO 2026, explorando nuevos enfoques para el tratamiento oncológico Un número récord de 64 presentaciones de investigación pone de relieve la solidez de Hengrui en I+D oncológica y su creciente...

• Press releases
• Country: United States

Median PFS Approaches 14 Months! 3SBio's PD-1/VEGF Bispecific Antibody Posts Impressive Data at ESMO 2026

SHANGHAI, Oct. 28, 2026 /PRNewswire/ -- At the 2026 European Society for Medical Oncology (ESMO) Congress, 3SBio presented long-term follow-up results from a Chinese Phase II clinical study of SSGJ-707 combined with chemotherapy as a first-line treatment for advanced non-small cell lung...

• Press releases
• Country: United States

From China to the Global Stage: Hengrui Showcases Innovative Research at ESMO Congress 2026, Exploring New Approaches to Oncology Treatment

Record 64 Research Presentations Highlight Hengrui's Oncology R&D Strength and Growing International Reach SHANGHAI and MADRID, Oct. 28, 2026 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) Congress 2026 recently concluded in Madrid. As a leading innovator in China's...

• Press releases
• Country: Canada

From China to the Global Stage: Hengrui Showcases Innovative Research at ESMO Congress 2026, Exploring New Approaches to Oncology Treatment

Record 64 Research Presentations Highlight Hengrui's Oncology R&D Strength and Growing International Reach MADRID and SHANGHAI, Oct. 27, 2026 /PRNewswire/ -- The European Society for Medical Oncology (ESMO) Congress 2026 recently concluded in Madrid. As a leading innovator in China's...

• Country: Cyprus

Natera technology featured in 25 abstracts at ESMO congress